These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9053516)

  • 1. Granulocyte-macrophage colony-stimulating factor with induction treatment of acute myelogenous leukemia.
    Adkins DR; Brown RA; DiPersio JF
    J Clin Oncol; 1997 Feb; 15(2):862-3. PubMed ID: 9053516
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acute myelogenous leukaemia.
    Löwenberg B
    J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment of acute myeloblastic leukemia with rhGM-CSF and standard induction chemotherapy.
    Valent P; Sillaber C; Geissler K; Andreeff M; Tafuri A; Vieder L; Schulz G; Lechner K; Bettelheim P
    Cancer Invest; 1993; 11(2):229-34. PubMed ID: 8462024
    [No Abstract]   [Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
    Zittoun R; Suciu S; Mandelli F; de Witte T; Thaler J; Stryckmans P; Hayat M; Peetermans M; Cadiou M; Solbu G; Petti MC; Willemze R
    J Clin Oncol; 1996 Jul; 14(7):2150-9. PubMed ID: 8683249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin dependent diabetes mellitus induced by chemotherapy and granulocyte, macrophage--colony stimulating factor.
    Geetha N; Lali VS; Hussain BM; Nair MK
    J Assoc Physicians India; 1999 Aug; 47(8):835. PubMed ID: 10778638
    [No Abstract]   [Full Text] [Related]  

  • 6. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.
    Stone RM; Berg DT; George SL; Dodge RK; Paciucci PA; Schulman P; Lee EJ; Moore JO; Powell BL; Schiffer CA
    N Engl J Med; 1995 Jun; 332(25):1671-7. PubMed ID: 7760868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute myeloid leukemia in older adults: time to reflect?
    Ravandi F
    Leuk Lymphoma; 2006 Apr; 47(4):579-80. PubMed ID: 16886271
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
    de la Rubia Comos J
    Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.
    Estey E; Thall P; Andreeff M; Beran M; Kantarjian H; O'Brien S; Escudier S; Robertson LE; Koller C; Kornblau S
    J Clin Oncol; 1994 Apr; 12(4):671-8. PubMed ID: 7512125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timed-sequential chemotherapy as induction and/or consolidation regimen for younger adults with acute myelogenous leukemia.
    Thomas X; Dombret H
    Hematology; 2007 Feb; 12(1):15-28. PubMed ID: 17364988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia.
    Strati P; Tong WG; Vitale C; Wierda WG; O'Brien S; Brown JR; Weng WK; Kipps T; Keating MJ; Ferrajoli A
    Leuk Lymphoma; 2015 Jun; 56(6):1878-80. PubMed ID: 25311497
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo effect of granulocyte-macrophage colony-stimulating factor on the kinetics of human acute myeloid leukemia cells.
    Aglietta M; De Felice L; Stacchini A; Petti MC; Bianchi AC; Aloe Spiriti MA; Sanavio F; Apra F; Piacibello W; Stern AC
    Leukemia; 1991 Nov; 5(11):979-84. PubMed ID: 1961040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia.
    Archimbaud E; Fenaux P; Reiffers J; Cordonnier C; Leblond V; Travade P; Troussard X; Tilly H; Auzanneau G; Marie JP
    Leukemia; 1993 Mar; 7(3):372-7. PubMed ID: 8445942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-macrophage colony-stimulating factor in post-remission therapy of acute myeloid leukemia.
    Sousa AB; Fernandes JP; Costa I; Ferreira G; Nunes O; Ribeiro P; Neves A; Cruz E; Aveiro F; Rodrigues AS; Bernardo M; Conduto A; Gonçalves AJ; Monteiro A; Sousa M; Soares VH; Veiga J; Gouveia J
    Hematol Cell Ther; 1998 Apr; 40(2):63-6. PubMed ID: 9615248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A network meta-analysis of randomized controlled trials of induction treatments in acute myeloid leukemia in the elderly.
    Ziogas DC; Voulgarelis M; Zintzaras E
    Clin Ther; 2011 Mar; 33(3):254-79. PubMed ID: 21600383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern strategies in therapy of acute myeloid leukemia (AML) in adulthood. I. Primary treatment of de novo AML].
    Jehn U; Dengler R; Petrides PE
    Internist (Berl); 1996 Jun; 37(6):661-8. PubMed ID: 8768003
    [No Abstract]   [Full Text] [Related]  

  • 18. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-CSF in combination with cytotoxic chemotherapy in AML patients.
    Bettelheim P; Muhm M; Valent P; Geissler K; Andreeff M; Haimi J; Sillaber C; Hinterberger W; Vieder L; Schulz G
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():127-30. PubMed ID: 2202464
    [No Abstract]   [Full Text] [Related]  

  • 20. Current problems in the treatment of acute myelocytic leukemia (AML) and some possible solutions.
    Preisler HD; Raza A
    Leukemia; 1992; 6 Suppl 2():81-4. PubMed ID: 1578951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.